Oh... there are MANY who will and have every right to do so
because
PRICEY FISH OIL of a small unknown pharma company is a TARGET!
AMRN's Vascepa stands to disrupt the status quo of BIG PHARMA statin manufacturers... expect assault from them the closer to success V comes. BIG $$$$$$$ are at risk for BP to lose if V is approved and eats away at sales!!!!
And other random CHAOS often comes to AMRN from spillover caused by stupidity! It all adds to volume & revenue... TRUTH is merely OPTIONAL, unfortunately!
Market Data 
Markets 
AI
